PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,842 Cr | ₹4,175 Cr | ₹3,903 Cr | ₹3,854 Cr | ₹3,252 Cr |
What is the latest Total Liabilities ratio of PFIZER ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹4,842 Cr |
| Mar2024 | ₹4,175 Cr |
| Mar2023 | ₹3,903 Cr |
| Mar2022 | ₹3,854 Cr |
| Mar2021 | ₹3,252 Cr |
How is Total Liabilities of PFIZER Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,842 Cr | 15.98 | |
| Mar2024 | ₹4,175 Cr | 6.96 | |
| Mar2023 | ₹3,903 Cr | 1.29 | |
| Mar2022 | ₹3,854 Cr | 18.48 | |
| Mar2021 | ₹3,252 Cr | - | |
Compare Total Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,022.1 Cr | -0.8% | 4.9% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.8% |
4.9% |
19.7% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses